中國石油(00857.HK)首個自主開發特高含硫氣田成功產氣及進入管網
中國石油(00857.HK)公布,旗下中石油西南油氣田公司鐵山坡氣田中心站於昨日(28日),透過遠程操控開啟「坡002-H4井」一級節流閥,該氣井的天然氣成功產出並進入管網,標誌著中國石油首個自主開發的特高含硫氣田首氣成功,氣田井控和集輸系統將進入72小時考核階段。
鐵山坡氣田飛仙關組氣藏位於四川省達州市宣漢縣及萬源市境內,是目前國內綜合含硫量最高的高含硫整裝氣田,亦是中石油首個自主開發的大型特高含硫氣田,硫化氫含量高達14.19%至15.54%。
根據開發方案,開發產能建設項目共鑽井和地面配套6口新井,測試累計獲得日產氣量超過1,000萬立方米,井均日產氣量171萬立方米。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.